Giovanni Pellicanò

Learn More
BACKGROUND Long term efficacy of raltegravir (RAL)-including regimens in highly pre-treated HIV-1-infected patients has been demonstrated in registration trials. However, few studies have assessed durability in routine clinical settings. METHODS Antiretroviral treatment-experienced patients initiating a RAL-containing salvage regimen were enrolled.(More)
Purpose of the study To further investigate CPK increases and muscle symptoms in a cohort of HIV-infected patients receiving ral-tegravir-based HAART compared with a control cohort with similar characteristics receiving darunavir-based HAART. Methods The SCOLTA Project is a prospective, observational, multicenter study created to assess the incidence of(More)
  • 1